The MSAA is expanding its patient-centered research network to include more than 1,000 people with MS receiving care at 20 ...
The National MS Society has released a new report detailing the lived experiences of people with MS and highlighting unmet ...
Neurophet has entered a collaboration to advance software that uses AI to examine brain MRI scans for signs characteristic of ...
The benefits of frexalimab in people with relapsing MS have been sustained for up to three years in a clinical trial, data ...
World MS Day on May 30 unites advocates to push for earlier diagnoses of multiple sclerosis, better medical training, and ...
An app-based peer support program boosted self-confidence and social connection for people newly diagnosed with multiple ...
Neuropsychiatric care in MS has seen major progress over the last 40 years, though more remains to be done, an expert in the ...
To many caregivers, moving a spouse into assisted living feels like a failure. For columnist Lindsay Kelly, it was an act of love.
Columnist Ben Hofmeister makes a presentation at this year's meeting of the Consortium of Multiple Sclerosis Centers on MS quality of care.
Many women with multiple sclerosis (MS) have misconceptions about how the disease may affect pregnancy and childbirth, a ...
Kesimpta was more effective than Aubagio for highly active relapsing multiple sclerosis. It was much more likely to reduce relapses, MRI lesion activity, and disability progression over two years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results